relación de la tiroglobulina pre-ablación con la recurrencia ...

More documents

Recommendations

Info

10. Sawka AM, Orlov S, Gelberg J, Stork B, Dowar M, Shaytzag M et al. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well- differentiated thyroid carcinoma. Head Neck. 2008 Jun;30(6):693-700. 11. Asit Arora, Neil S. Tolley, R. Michael Tuttle. Editores. A Practical Manual of Thyroid and Parathyroid Disease. 1a ed. London, UK: Blackwell Publishing; 2010. 12. Lee HJ, Rha SY, Jo YS, Kim SM, Ku BJ, Shong M et al. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma. Am J Clin Oncol. 2007 Feb;30(1):63-8. 13. Giovanella L, Ceriani L, Ghelfo A, Keller F. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma. Clin Chem Lab Med. 2005;43(8):843-7. 14. Ronga G, Filesi M, Ventroni G, Vestri AR, Signore A. Value of the first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma. Eur J Nucl Med. 1999 Nov;26(11):1448-52. 15. Toubeau M, Touzery C, Arveux P, Chaplain G, Vaillant G, Berriolo A et al. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med. 2004 Jun;45(6):988-94. 16. Kim TY, Kim WB, Kim ES, Ryu JS, Yeo JS, Kim SC et al. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2005 Mar;90(3):1440-5. 17. Vaisman A, Orlov S, Yip J, Hu C, Lim T, Dowar M et al. Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma. Head Neck. 2010 Jun;32(6):689-98. 18. Hall FT, Beasley NJ, Eski SJ, Witterick IJ, Walfish PG, Freeman JL. Predictive value of serum thyroglobulin after surgery for thyroid carcinoma. Laryngoscope. 2003 Jan;113(1):77- 81. 19. Garavito G. Factores pronósticos para la recaída en pacientes con cáncer papilar de tiroides. Rev Colomb CanCeRol 2005; 9(2): 21-30. 57
20. David S. Cooper. Editor. Medical Management of Thyroid Disease. 2a ed. The Johns Hopkins University School: Informa Healthcare USA; 2008. 21. Piñeros M, Pardo C, Cantor LF, Hernández G, Martínez T, Palomino MS, et al. Registro institucional de cáncer del instituto nacional de cancerología, E.S.E. Resultados principales, año 2001. Rev. Col. Cancerol. 2002; 6(3):4-49. 22. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Thyroid Carcinoma [en línea]. V.1.2010. [fecha de acceso 23 de agosto de 2010]. URL disponible en: www.nccn.org 23. Lin JD. Thyroglobulin and human thyroid cancer. Clin Chim Acta. 2008 Feb;388(1-2):15-21. 24. Kloos RT, Mazzaferri EL. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab. 2005 Sep;90(9):5047-57. 25. Giovanella L, Ceriani L, Maffioli M. Postsurgery serum thyroglobulin disappearance kinetic in patients with differentiated thyroid carcinoma. Head Neck. 2010 May;32(5):568-71. 26. Ma C, Xie J, Lou Y, Gao Y, Zuo S, Wang X. The role of TSH for 18F-FDG-PET in the diagnosis of recurrence and metastases of differentiated thyroid carcinoma with elevated thyroglobulin and negative scan: a meta-analysis. Eur J Endocrinol. 2010 Aug;163(2):177- 83. 27. Gutiérrez-Cardo AL, Rodríguez-Rodríguez JR, Borrego-Dorado I, Navarro-González E, Tirado JL, Vázquez-Albertino R. Pacientes tratados por carcinoma diferenciado de tiroides con rastreos de 131 I negativos y niveles de tiroglobulina elevada. Una evolución posible. Rev Esp Med Nucl. 2007 May-Jun;26(3):138-45. 28. Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001 Apr;86(4):1447-63. 29. Bernard A. Rosner. Fundamentals of biostatistics. 2 a ed. Duxbury Press USA; 1986. 30. Malandrino P, Latina A, Marescalco S, Spadaro A, Regalbuto C, Fulco RA, et al. Risk- adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin. J Clin Endocrinol Metab. 2011;96(6):1703-9. 31. Doi SA, Woodhouse NJ, Thalib L, Onitilo A. Ablation of the Thyroid Remnant and I-131 Dose in Differentiated Thyroid Cancer: A Meta-Analysis Revisited. Clin Med Res. 2007;5(2):87–90. 58
Page 1 and 2:
RELACIÓN DE LA TIROGLOBULINA PRE-A
Page 3 and 4:
“La Universidad del Rosario no se
Page 5 and 6:
I. Resumen…… pag 1 Abstract…
Page 7 and 8:
11.6.4.3 En pacientes sin persisten
Page 9 and 10:
Lista de Figuras Figura 1. Medianas
Page 11 and 12:
Abstract Introduction: Differentiat
Page 13 and 14:
permitirá tener mayor claridad ace
Page 15 and 16: 3.1 Introducción III. Marco Teóri
Page 17 and 18: La mayor prevalencia en mujeres par
Page 19 and 20: los ganglios linfáticos e histolog
Page 21 and 22: anti-Tg tiene una probabilidad de i
Page 23 and 24: mostraron que respecto a la Tg pre-
Page 25 and 26: astreo pos-terapia que habían pasa
Page 27 and 28: ueno en pacientes mayores de 40 añ
Page 29 and 30: 6.1 Tipo y diseño general del estu
Page 31 and 32: Nombre Definición Conceptual Deter
Page 33 and 34: Nombre Definición Conceptual Halla
Page 35 and 36: Nombre Definición Definición Oper
Page 37 and 38: Nombre Definición Conceptual ecogr
Page 39 and 40: seguimiento (pre, post tres a seis
Page 41 and 42: XI. Resultados Se revisaron un tota
Page 43 and 44: la frecuencia de recurrencia/persis
Page 45 and 46: 11.4.2 Evaluación imagenológica e
Page 47 and 48: Al realizar la prueba de Wilcoxon p
Page 49 and 50: Me 80 70 60 50 40 30 20 10 0 Tabla
Page 51 and 52: 11.6.3.2 Análisis de la tiroglobul
Page 53 and 54: los ganglios linfáticos, el tamañ
Page 55 and 56: 140 120 100 80 60 40 20 0 Me ¬ Fig
Page 57 and 58: ese momento y el segundo semestre p
Page 59 and 60: determina el éxito del tratamiento
Page 61 and 62: Hasta ahora pocos estudios han inve
Page 63 and 64: pudieron tener relación con las di
Page 65: XV. Referencias 1. Davies L, Welch
Page 69 and 70: 16.1 Anexo 1 XVI. Anexos RELACIÓN
Page 71: 31. Si se realizó la medición, lo
show all

relación de la tiroglobulina pre-ablación con la recurrencia ...

Create successful ePaper yourself

Delete template?

Save as template?